Legionella Testing Market to Grow with a CAGR of 7.62% through 2028

Rising prevalence of chronic diseases are expected to drive the Global Legionella Testing Market in the forecast period 2024-2028.

According to TechSci Research report, “Legionella Testing Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Legionella Testing Market stood at USD 289.21 million in 2022 and is anticipated to grow with a CAGR of 7.62% in the forecast period, 2024-2028. The Global Legionella Testing Market is driven by several key factors that contribute to its growth and significance in ensuring public health and safety. Some of the prominent drivers include Rising Incidence of Legionnaires' Disease: The increasing occurrence of Legionnaires' disease cases globally is a significant driver. This respiratory illness, caused by Legionella bacteria, has prompted heightened awareness and the need for regular testing to prevent outbreaks. Stringent Regulatory Requirements: Governments and health authorities in many regions have imposed strict regulations and guidelines that mandate Legionella testing, particularly in high-risk facilities like hospitals, hotels, and industrial settings. Compliance with these regulations fuels market growth. High-Risk Environments: Facilities with complex water systems, such as cooling towers, hot tubs, and large buildings with plumbing networks, are at higher risk for Legionella contamination. Testing is essential in these environments to mitigate the risk of Legionnaires' disease outbreaks. Advancements in Testing Technology: The development of advanced testing methods, including PCR (Polymerase Chain Reaction) and Next-Generation Sequencing (NGS), has made Legionella detection faster, more accurate, and more accessible, driving increased adoption. Increased Awareness: Growing awareness among building owners, healthcare professionals, and the general public about the dangers of Legionella and the importance of testing has contributed to market growth.

The market is witnessing substantial expansion, driven by factors such as the increasing occurrence of pneumonia and illnesses associated with Legionella bacteria, along with a growing demand for advanced, rapid diagnostic techniques and advancements in bacterial testing technology. Legionella pneumonia, while relatively rare as a cause of community-acquired pneumonia, presents varying global incidence rates, influenced by geographical, seasonal, and demographic factors. For instance, a study published in August 2021 titled 'Community-Acquired Pneumonia' reported worldwide estimates ranging from 1.5 to 14 cases per 1000 individuals annually, with increasing rates as individuals age. Given this significant occurrence, early and effective preventive measures are deemed essential, driving the expansion of the Legionella testing market. A report from the European Centers for Disease Prevention and Control in May 2022 highlighted that legionnaires' disease remains a relatively infrequent respiratory infection, with a reported overall rate of 1.9 cases per 100,000 individuals in Europe in 2020. Notably, France, Germany, Italy, and Spain accounted for the majority of registered cases. Legionnaires' disease is non-contagious but can be contracted through exposure to contaminated water droplets and mist. Consequently, an upsurge in legionnaires' disease cases is anticipated to drive market growth. In summary, the aforementioned factors are poised to stimulate market expansion during the forecast period. Nevertheless, challenges related to the sensitivity of diagnostic tests may serve as a restraining factor affecting market growth in the foreseeable future.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Legionella Testing Market”

The Global Legionella Testing Market is driven by several key factors: Increasing Awareness and Regulatory Compliance: Growing awareness of the health risks associated with Legionella bacteria and the need for preventive measures has led to stricter regulatory requirements in various industries. This, in turn, has driven demand for Legionella testing to ensure compliance and public safety. Rising Incidence of Legionnaires' Disease: The increasing occurrence of Legionnaires' disease, a severe form of pneumonia caused by Legionella bacteria, has heightened the urgency for Legionella testing. The aging population, urbanization, and climate changes are contributing to a higher incidence of this disease, necessitating robust testing protocols. Advancements in Testing Technologies: Technological innovations, such as PCR and NGS, have improved the speed and accuracy of Legionella testing, making it more accessible and efficient for a wider range of facilities. Globalization and International Travel: International travel and tourism facilitate the cross-border spread of Legionella bacteria. Collaborative efforts and testing are crucial to prevent outbreaks in high-risk settings like hotels and cruise ships. Water Management Programs: The adoption of comprehensive water management programs in industries like healthcare and hospitality emphasizes routine Legionella testing as a preventive measure. Public Health Concerns: High-profile Legionella outbreaks have raised public health concerns, increasing the demand for Legionella testing in various facilities and industries. These drivers collectively underscore the growing importance of Legionella testing in safeguarding public health and ensuring compliance with regulations, thereby fueling the growth of the Global Legionella Testing Market.

The Global Legionella Testing Market is segmented into test type, application, end user, regional distribution, and company.

Based on test type, the market is segmented into Culture Method, Urinary Antigen Test (UAT), Direct Fluoroscent Antibody (DFA) Test, Polymerase Chain Reaction (PCR), Other. The Urinary Antigen Test (UAT) segment is expected to rise in the forecast period. This is attributed because it provides rapid outcomes, with usually same-day results. Additionally, UAT is not resource-specific and technically intensive like culture-based tests.

Based on region, the market is segmented into North America, Europe, Asia Pacific, Central & South America, Middle East & Africa. The North America segment was dominated the market in 2022. This is due to increasing cases of patients suffering from legionella infections and the presence of key players in this region. Additionally, to manage the prevalence of legionnaires diseases, the Government of the United States is increasing awareness among the general public with the environmental legionella isolation techniques Evaluation (ELITE) program, which may further augment the growth of the market.

Major companies operating in Global Legionella Testing Market are:

• Thermo Fisher Scientific Inc.
• BioMérieux SA
• Becton, Dickinson and Company
• Aquacert Ltd
• Qiagen NV
• Bio-Rad Laboratories
• Hologic Inc.
• Takara Bio Inc.
• Beckman Coulter Inc.
• Roche Diagnostics

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The Global Legionella Testing Market is primarily driven by the rising awareness of Legionella-related health risks and stringent regulatory compliance in various industries. Factors such as the increasing incidence of Legionnaires' disease, advancements in testing technologies, globalization, and international travel contribute to the market's growth. Additionally, the adoption of water management programs, driven by public health concerns and high-profile outbreaks, fuels the demand for routine Legionella testing in facilities and industries worldwide. These drivers collectively emphasize the critical role of Legionella testing in ensuring public safety and compliance with regulations, propelling market expansion contributes to foster the demand for Global Legionella Testing Market in the forecast period” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Legionella Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Test Type (Culture Method, Urinary Antigen Test (UAT), Direct Fluoroscent Antibody (DFA) Test, Polymerase Chain Reaction (PCR), Other), By Application (Clinical Testing Method and Environmental Testing Method), By End User (Hospital and Clinics, Diagnostics Laboratory), By Region and Competition” has evaluated the future growth potential of Global Legionella Testing Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Legionella Testing Market.

Contact

Techsci Research LLC

420 Lexington Avenue,

Suite 300, New York

United States- 10170

Tel: +13322586602

Email: [email protected]